Table 1.
Virus | Group | Family | Inhibition of | Cell Line/Animal Model | Antiviral Activity (EC50 or IC50) | Cell Toxicity (CC50) | Ref. |
---|---|---|---|---|---|---|---|
MERS-CoV | (+)ssRNA | Coronaviridae | Viral replication | Vero E6 cells | 1.2 μM | >10 μM | [13] |
SARS-CoV | (+)ssRNA | Coronaviridae | Viral replication | Vero E6 cells | 4.9 μM | >10 μM | [13] |
ZIKA | (+)ssRNA | Flaviviridae | Viral RNA and protein synthesis virus-mediated cell death | RPE cells | 0.01 μM | >10 μM | [14] |
HCV | (+)ssRNA | Flaviviridae | Viral replication | Huh-7 cells | 12 nM | >44 μM | [19] |
Poliovirus | (+)ssRNA | Picornaviridae | Viral replication RNA polymerase | HeLa cells | 0.3 μM | >100 μM | [15] |
Influenza A virus (IAV) | (−)ssRNA | Orthomyxoviridae | Viral RNA transcription and replication virus entry | RPE cells | 0.068 μM | >10 μM | [16] |
HIV | ssRNA-RT | Retroviridae | Viral replication | U373-MAGI-CXCR4CEM cells | 16.3 nM | [17] | |
MuLV | ssRNA-RT | Retroviridae | Viral replication | U373-MAGI-CXCR4CEM ls/Murine AIDS mouse model | 1.6 nM | [17] | |
CVB3 | (+)ssRNA | Picornaviridae | Viral proliferation Viral replication Early step of virus infection |
Vero cells HeLa cells |
0.4 μM 2 μM |
>50 μM >50 μM |
[18] |
EV71 | (+)ssRNA | Picornaviridae | Viral proliferation Viral replication | Vero cells | 1 μM | >50 μM | [18] |
HRV | (+)ssRNA | Picornaviridae | Viral RNA synthesis | HeLa cells/Mouse | 1–5 μM | >50 μM | [18,22] |
Sindbis virus (SINV) | (+)ssRNA | Togaviridae | Virus production | Vero cells | >2 logs (at 3 μM) | [16] | |
HSV-1 | dsDNA | Herpesviridae | Virus production | RPE cells | >4 logs (at 3 μM) | [16] |
RPE cells: retinal pigment epithelium cells; U373-MAGI-CXCR4CEM cells: cells expressing the CD4 receptor and the CXCR4 coreceptor.